Tower View Investment Management & Research LLC Viatris Inc Transaction History

Tower View Investment Management & Research LLC

$173 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 03, 2022	SELL	$12.09 - $14.68 $1,499 - $1,820	-124 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$13.25 - $15.13 $1,643 - $1,876	124 New	124 $2,000

Others Institutions Holding VTRS

# of Institutions

1,103

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

Vanguard Group Inc Valley Forge, PA

141M
Shares

$1.86 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

92.7M
Shares

$1.23 Billion
0.02% of portfolio
State Street Corp Boston, MA

63.1M
Shares

$834 Million
0.03% of portfolio
Chris Davis Davis Selected Advisers | Tucson, Az

62.6M
Shares

$828 Million
4.18% of portfolio
Price T Rowe Associates Inc Baltimore, MD

48.8M
Shares

$645 Million
0.07% of portfolio

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $16B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower View Investment Management & Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tower View Investment Management & Research LLC with notifications on news.

Account